Assyro AI

Orange Book product · Brand (NDA)

ZYPITAMAG

PITAVASTATIN MAGNESIUM

Brand (NDA)NDA 208379DISCN MEDICURE

At a glance

Jul 14, 2017

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 14, 2017

    9 yr 1 mo ago

  2. Today

  3. Patent 8829186 expires

    Listed drug substance patent expiration.

    Jan 19, 2031

    in 4 yr 8 mo

Pharmaceutical detail

Active ingredient

PITAVASTATIN MAGNESIUM

Strength

EQ 1MG BASE

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

NDA 208379

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8829186Jan 19, 2031in 4 yr 8 mo
SubstanceProduct
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.